Keywords: uk, strakan, merge, french, rival, proskelia, london-listing

The UK's Strakan to merge with French rival ProSkelia for London-listing

Article | 14 June 2004

Print This

UK biotechnology firm Strakan Pharmaceuticals is to marry its French rival, Aventis' spin-off Proskelia, in an all stock deal, with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in